TE_38282
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | THE1B |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | -, LINC02968 |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 1036.93 |
| Counts of samples | TCGA_tumor:919; TCGA_normal:0; GTEx:0 |
| TSS | chrX(+):1679561 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38282.1 | LINC02968 | Chimeric | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1755684,1755985,1762959,1762979 |
| teRNA_38282.2 | - | Intergenic | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1726318,1726490,1730878,1730898 |
| teRNA_38282.3 | - | Intergenic | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1730878,1730982,1732516,1732536 |
| teRNA_38282.4 | LINC02968 | Chimeric | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1730878,1732723,1733950,1734196,1741931,1741951 |
| teRNA_38282.5 | LINC02968 | Chimeric | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1732516,1732723,1733950,1734196,1741931,1741951 |
| teRNA_38282.6 | - | Intergenic | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1730878,1731013,1732516,1732536 |
| teRNA_38282.7 | LINC02968 | Chimeric | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1751287,1751346,1755684,1755985,1762959,1762979 |
| teRNA_38282.8 | LINC02968 | Chimeric | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1733953,1734196,1741931,1741951 |
| teRNA_38282.9 | LINC02968 | Chimeric | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1733953,1734196,1755684,1755985,1762959,1762979 |
| teRNA_38282.10 | LINC02968 | Chimeric | Non-coding | Non-coding | chrX(+):1679562,1679609,1726067,1726154,1733950,1734196,1741931,1741951 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
